Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation

Clinical Cancer Research

Volumn 15, Issue 15, 2009, Pages 4944-4953

  Beatty, Gregory L ^a,b   Smith, Jasmine S ^b   Reshef, Ran ^a,b   Patel, Kunal P ^a   Colligon, Theresa A ^a   Vance, Barbara A ^a   Frey, Noelle V ^a,b   Johnson, F Brad ^b   Porter, David L ^a,b   Vonderheide, Robert H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER THERAPY; CD8+ T LYMPHOCYTE; CELL AGING; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; FEMALE; GRAFT VS LEUKEMIA EFFECT; HUMANS; INTERFERON-GAMMA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MIDDLE AGED; STEM CELL TRANSPLANTATION; TELOMERE; YOUNG ADULT;

EID: 68049137903     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-3332     Document Type: Article

References (46)

1. Wu CJ, Ritz J. Induction of tumor immunity following allogeneic stem cell transplantation. Adv Immunol 2006;90:133-173 (Pubitemid 43765800)
2. Molldrem JJ, Lee PP, Wang C, et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 2000;6:1018-1023
3. Rusakiewicz S, Molldrem JJ. Immunotherapeutic peptide vaccination with leukemia-associated antigens. Curr Opin Immunol 2006;18:599-604. (Pubitemid 44311451)
4. Molldrem J, Dermime S, Parker K, et al. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 1996;88:2450-2457 (Pubitemid 26327493)
5. Gannage M, Abel M, Michallet AS, et al. Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy. J Immunol 2005;174:8210-8218 (Pubitemid 40806333)
6. + T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation. Blood 2003;102:2892-2900
7. Greiner J, Schmitt M, Li L, et al. Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches. Blood 2006;108:4109-4117 (Pubitemid 44913282)
8. Loren AW, Porter DL. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant 2008;41:483-493
9. Altman JD, Moss PAH, Goulder PJR, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996;274:94-96
10. Steinert S, White DM, Zou Y, Shay JW, Wright WE. Telomere biology and cellular aging in nonhuman primate cells. Exp Cell Res 2002;272:146-152 (Pubitemid 34920682)
11. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315-2320
12. Inoue K, Ogawa H, Yamagami T, et al. Longterm follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood 1996;88:2267-2278 (Pubitemid 26307931)
13. van Baren N, Chambost H, Ferrant A, et al. PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells. Br J Haematol 1998;102:1376-1379 (Pubitemid 28435230)
14. Lawrence HJ, Rozenfeld S, Cruz C, et al. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 1999;13:1993-1999
15. Carter BZ, Milella M, Altieri DC, Andreeff M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood 2001;97:2784-2790
16. Bellantuono I, Gao L, Parry S, et al. Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL. Blood 2002;100: 3835-3837 (Pubitemid 35303962)
17. Kessler JH, Beekman NJ, Bres-Vloemans SA, et al. Efficient identification of novel HLA-A(*) 0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J Exp Med 2001;193:73-88.
18. Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999;10:673-679
19. Andersen MH, Pedersen LO, Becker JC, Straten PT. Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients. Cancer Res 2001;61:869-872
20. + virus-specific cytotoxic T lymphocytes. J Med Virol 1994;43:103-110
21. Bednarek MA, Sauma SY, Gammon MC, et al. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J Immunol 1991;147:4047-4053
22. Kannagi M, Shida H, Igarashi H, et al. Target epitope in the tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol 1992;66:2928-2933
23. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHCligands and peptide motifs. Immunogenetics 1999;50:213-219 (Pubitemid 30099526)
24. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994;152:163-175 (Pubitemid 24974579)
25. Chen DY, Vance BA, Thompson LB, Domchek SM, Vonderheide RH. Differential lysis of tumors by polyclonal T cell lines and T cell clones specific for hTERT. Cancer Biol Ther 2007;6:1991-1996
26. + T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281: 65-78.
27. Rubio V, Stuge TB, Singh N, et al. Ex vivo identification, isolation, and analysis of tumor-cytolytic T cells. Nat Med 2003;9:1377-1382 (Pubitemid 37466186)
28. + T cells leads to reversible immune dysfunction. Nat Med 2006;12:1198-1202
29. + T cell survival in HIV infection. J Exp Med 2006;203: 2281-2292
30. Effros RB. Replicative senescence of CD8 T cells: potential effects on cancer immune surveillance and immunotherapy. Cancer Immunol Immunother 2004;53:925-933
31. + T-cell replicative senescence in human aging. Immunol Rev 2005; 205:147-157
32. Vallejo AN. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005;205:158-169
33. + T cells. Blood 2003;101:2711-2720
34. Sallusto F, Lenig D, Forster R, LippM, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-712 (Pubitemid 129515761)
35. + T lymphocytes. J Immunol 2007; 178:4112-4119
36. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460 (Pubitemid 120014963)
37. Effros RB, Allsopp R, Chiu CP, et al. Shortened telomeres in the expanded CD28-8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996;10:F17-22. (Pubitemid 26229506)
38. Dagarag M, Ng H, Lubong R, Effros RB, Yang OO. Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J Virol 2003;77:3077-3083 (Pubitemid 36228093)
39. Effros RB. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev Comp Immunol 1997;21:471-478
40. + counterparts. J Immunol 1996;156:3587-3590
41. Bestilny LJ, Gill MJ, Mody CH, Riabowol KT. Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS 2000;14:771-780
42. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995;16:413-425
43. Heining C, Spyridonidis A, Bernhardt E, et al. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Bone Marrow Transplant 2007;39:613-622 (Pubitemid 46729053)
44. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003;300:339-342
45. + T lymphocytes. Nature 2003; 421:852-856
46. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003;300:337-339 (Pubitemid 36433726)